IRulya Therapeutics Inc. Share Price

IRulya Therapeutics Inc. Share Price

NASDAQ: IRLA
$33.12
-$0.38 (-1.15%) Last updated on 03 Nov, 2026 | 02:28 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

IRulya Therapeutics Inc. Stock Performance

Open
$32.74
Prev. Close
$33.50
Circuit Range
N/A
Day Range
$32.74 - $33.71
Year Range
$27.61 - $40.33
Volume
3,143
Average Traded
$33.08

IRulya Therapeutics Inc. Share Price Today

As of 3 November 2026, IRulya Therapeutics Inc.'s share price is $33.12. The stock opened at $32.74, compared to its previous close of $33.50. During today's trading session, IRulya Therapeutics Inc.'s share price traded between $32.74 and $33.71, with an average price of $33.23. Over the past 52 weeks, the stock has recorded a high of $40.33 and a low of $27.61. In terms of performance, IRulya Therapeutics Inc.'s share price has risen by 0.35% over the last six months and is up 0.35% on a year-on-year basis.

IRulya Therapeutics Inc. Share Price Chart

Line chart of the IRulya Therapeutics Inc. price trend over the selected period. The price fell overall, ranging from 31.66 to 33.71, ending at 33.12.
$32.74$33.71
L
Show Current Price
H

IRulya Therapeutics Inc. Stock Fundamentals & Key Indicators

Market Cap
N/A
PE Ratio (TTM)
N/A
Dividend Yield
N/A
EPS (TTM)
N/A
Revenue (TTM)
N/A
Return On Equity (TTM)
N/A
Profit Margin
N/A
Debt to Equity
N/A
Quarterly Earnings Growth YoY
N/A

About IRulya Therapeutics Inc.

IRulya Therapeutics Inc is committed to transforming the lives of patients with serious, underserved diseases by developing disease-modifying therapies. The company is currently developing LAM-001 for the treatment of pulmonary hypertension associated with interstitial lung disease (PH-ILD), bronchiolitis obliterans syndrome post-lung transplant (BOS), and sarcoidosis-associated pulmonary hypertension (SAPH). A Phase 2a study in PH patients has been completed; a Phase 2 clinical study in BOS patients is ongoing; a Phase 2b clinical study in PH-ILD is ongoing; and a Phase 2 clinical study in SAPH is ongoing.

IRulya Therapeutics Inc. Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Nov 2026
$32.74
$32.80
-0.62%
Oct 2026
$27.61
$33.00
N/A

IRLA Share Price FAQs